大豆异黄酮通过抑制NLRP3炎症小体介导的神经元焦亡改善脑缺血再灌注损伤

Amelioration of cerebral ischemia-reperfusion injury by soy isoflavones via inhibiting NLRP3 inflammasome-mediated neuronal pyroptosis

  • 摘要: 目的: 探究大豆异黄酮(soy isoflavones,SI)抑制NOD样受体热蛋白结构域相关蛋白3(NOD-like receptor thermal protein domain associated protein 3,NLRP3)炎症小体介导的神经元焦亡对脑缺血再灌注损伤(cerebral ischemia-reperfusion injury,CIRI)的神经保护作用及其机制。方法: 将60只健康SD大鼠随机分为假手术组、模型组、SI组和SI+尼日利亚菌素(Nigericin)组。SI组连续灌胃21 d,1次/d(120 mg/kg)。采用线栓法建立大鼠大脑中动脉缺血/再灌注(middle cerebral artery occlusion/reperfusion,MCAO/R)模型,缺血2 h后拔除线栓进行再灌注;假手术组仅分离血管,不插入线栓。再灌注前5 min,SI+Nigericin组经尾静脉注射Nigericin(1 mg/kg)。再灌注24 h后,通过神经功能缺损评分、干湿重法测定脑组织含水量、2,3,5-三苯基氯化四氮唑(2,3,5-triphenyltetrazolium chloride,TTC)染色及苏木精—伊红(hematoxylin-eosin,HE)染色法评估脑损伤程度。采用免疫荧光和western blotting法检测焦亡相关蛋白表达,酶联免疫吸附试验(enzyme-linked immunosorbent assay,ELISA)法检测血清白细胞介素(interleukin,IL)-1β、IL-18含量及乳酸脱氢酶(lactate dehydrogenase,LDH)活性。结果: 与模型组相比,SI组大鼠神经功能缺损评分、脑组织含水量及脑梗死面积均显著降低(P<0.001),皮层病理学损伤明显减轻。SI组NLRP3、消皮素D(Gasdermin D,GSDMD)、GSDMD N端结构域(GSDMD N-terminal domain,GSDMD-N)、caspase-1、cleaved caspase-1、IL-18、IL-1β及IL-1β p17蛋白表达下调,血清IL-1β、IL-18含量及LDH活性降低(均P<0.05),脑组织中NLRP3和GSDMD-N荧光信号明显减弱。Nigericin可部分逆转SI的上述保护效应(P<0.05)。结论: SI通过抑制NLRP3炎症小体活化减少神经元焦亡,进而有效缓解CIRI,实现神经保护的生物学效应。

     

    Abstract: Objective: To explore the neuroprotective effect and mechanism of soy isoflavones (SI) on cerebral ischemia-reperfusion injury (CIRI) by inhibiting NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome-mediated neuronal pyroptosis. Methods: Sixty healthy Sprague-Dawley (SD) rats were randomly divided into sham group, model group, SI group and SI+Nigericin group. Rats in the SI group were pretreated with intragastric administration of SI (120 mg/kg) once daily for 21 consecutive days. The middle cerebralartery occlusion (MCAO) rat model was established by the suture-occluded method, and reperfusion was induced by withdrawing the suture after 2 hours of ischemia; the sham group only underwent vascular separation without suture insertion. Five minutes before reperfusion, rats in the SI+Nigericin group were injected with Nigericin (1 mg/kg) via the tail vein. Twenty-four hours after reperfusion, the severity of brain injury was assessed by neurological deficit score, brain water content (dry-wet weight method), 2, 3, 5-triphenyltetrazolium chloride (TTC) staining, and hematoxylin-eosin (HE) staining. The expression of pyroptosis-related proteins was measured by immunofluorescence staining and western blotting. The serum levels of interleukin (IL)-1β, IL-18 and the activity of lactate dehydrogenase (LDH) were measured by enzyme-linked immunosorbent assay (ELISA). Results: Compared with the model group, the SI group exhibited significantly reduced neurological deficit scores, brain water content, cerebral infarct volume (P<0.001), as well as obviously alleviated cortical pathological injury. In the SI group, the protein expression levels of NLRP3, Gasdermin D (GSDMD), GSDMD N-terminal domain (GSDMD-N), caspase-1, cleaved caspase-1, IL-18, IL-1β and IL-1β p17 were downregulated; serum IL-1β and IL-18 contents as well as LDH activity were reduced (all P<0.05), and the fluorescence signals of NLRP3 and GSDMD-N in brain tissues were obviously weakened. Nigericin could partially reverse the above protective effects of SI (P<0.05). Conclusion: SI reduces neuronal pyroptosis by inhibiting NLRP3 inflammasome activation, thereby effectively alleviating CIRI and exerting neuroprotective effects.

     

/

返回文章
返回